Clinical Trials List
2011-07-08 - 2013-06-30
Others
Terminated4
ICD-10E78.1
Pure hyperglyceridemia
ICD-9272.1
Pure hyperglyceridemia
-
Trial Applicant
EXCELSIOR PHARMATECH LABS.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 江福田 Division of Cardiovascular Diseases
- LIAN-YU LIN Division of Cardiovascular Diseases
- Kuo-Chin Huang Division of Family Medicine
- Kuo-Liong Chien Division of Cardiovascular Diseases
- Yi-Chih Wang Division of Cardiovascular Diseases
- 黃天祥 Division of Endocrinology
- Juey-Jen Hwang Division of Cardiovascular Diseases
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- 蘇大成 Division of Cardiovascular Diseases
- HUNG-JU LIN Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 李文興 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Yi-Heng Li Division of Cardiovascular Diseases
- 黃耀毅 Division of Cardiovascular Diseases
- Ju-Yi Chen Division of Cardiovascular Diseases
- 吳達仁 Division of Endocrinology
- Shih-Hung Chan Division of Cardiovascular Diseases
- Ping-Yen Liu Division of Cardiovascular Diseases
- Yen-Wen Liu Division of Cardiovascular Diseases
- Cheng-Han Lee Division of Cardiovascular Diseases
- Po-Sheng Chen Division of Cardiovascular Diseases
- 林志展 Division of Cardiovascular Diseases
- 李貽恆 Division of Cardiovascular Diseases
- 李威廷 Division of Cardiovascular Diseases
- Ting-Hsing Chao Division of Cardiovascular Diseases
- Chih-Hsin Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
249 participants
-
Global
0 participants
